The European School of Oncology recommends the Master in Molecular Oncology,
and we are endorsed by SEOM, SEAP and SEHH in Spain, and ACHO and UOMP in Latin America.
The European School of Oncology recommends the Master in Molecular Oncology,
and we are endorsed by SEOM, SEAP and SEHH in Spain, and ACHO and UOMP in Latin America.
The European School of Oncology recommends the Master in Molecular Oncology,
and we are endorsed by SEOM, SEAP and SEHH in Spain, and ACHO and UOMP in Latin America.
100% Online Training
All our courses, programs and masters are completely online, hosted on our own digital academic platform.
English / Spanish
Training is provided in Spanish and English: recorded classes, contact with teachers, evaluations, etc.
Academic Excellence
Our students receive updated training in the scientific processes and developments that are used today in the different biosanitary professions.
What is MOM?
The Master in Molecular Oncology is a training program thatis taught in private format from CEB and in official format in collaboration with the URJCaimed at clinical oncologists, pathologists, hematologists and other specialists in medicine.
or the bio-health field related to tumor disease.
It is a specialized postgraduate training initiative pioneer in Spain and unique in the world in this discipline.
It has more than 100 faculty members rigorously selected to offer the best molecular oncology professionals at the national and international molecular oncology level that are authors of the discovery they teach..
The MOM offers training in Molecular Oncology based on a multidisciplinary vision of the tumor disease, which has a positive impact on the care aspect.
The student will have access to
- Basic knowledge about the origin and development of cancers.
- Methodology of basic and clinical oncology research.
- Phenotypic expression patterns of tumors.
- Therapeutic approaches based on molecular pathways involved in carcinogenesis.
This program provides the cutting-edge training that oncology specialists require in the 21st century. Today, excellent clinical practice is inconceivable without knowledge of the molecular basis of the disease, and without a diagnosis, prognosis and treatment based increasingly on the molecular markers of each patient.
Why do a master's degree in Molecular Oncology?
Advanced Training
The training received by specialists linked to oncologic disease, during the medical degree and subsequent MIR specialization, does not address with sufficient time and detail the knowledge of the molecular basis of cancer. Today, excellent clinical practice is inconceivable without knowledge of the molecular basis of the disease.
State-of-the-art clinical practice
Diagnosis, prognosis and treatment based on the patient’s molecular pattern allows for state-of-the-art clinical practice. New therapeutic strategies are based on specific inhibitors of molecular targets, or on blocking or activating certain pathways. It is essential to provide training that allows professionals to learn about the molecular basis of cancer and patients to benefit from this knowledge.
Research Advances
Oncology in the 21st century is based on advances in research. Only a common translational research effort can bring these advances to the patient’s bedside. Research and training are the essential tools to address cancer in daily clinical practice. If any one of them is missing, the approach to the patient will not be correct.
Academic Program
Credits 60 ECTS
The syllabus has been structured according to the guidelines of RD 861/2010.
It will be completed in one year and consists of twelve compulsory subjects distributed in two semesters.
In the first semester, the basic knowledge of oncology and molecular pathology will be acquired and the foundations of research methodology in molecular oncology will be laid.
Contents
- Molecular basis of cancer
- Proto-oncogenes and oncogenes
- Tumor suppressor genes
- Cellular processes involved in carcinogenesis
- Molecular pathology techniques
- Molecular pathology in the clinic of solid tumors.
- Molecular pathology in the clinic of hematological tumors.
- Methodology of clinical research in oncology.
- Risk factors in neoplasms
- Pharmacology and antitumor agents
- New molecular therapies
Modality
The student accesses the recorded classes through the e-learning platform of the Centro de Estudios Biosanitarios . The presentation used by the professor during his presentation will be made available to the student. The student will be able to send queries to the teachers from the e-learning platform.
Duration
12 months.
Academic starting
September.
Qualification obtained
Master in Molecular Oncology
Private degree awarded by the Centro de Estudios Biosantiarios.
Academic and Scientific Advisory Board
Dr. Mónica López Barahona
Chief Academic Officer
D. in Chemical Sciences from the Complutense University of Madrid. General Academic Director of the Center for Biosanitary Studies.
Dr. Javier León Serrano
D. in Pharmacy from the University of Cantabria. Professor of Biochemistry and Molecular Biology at the University of Cantabria.
Dr. Miguel Ángel Piris Pinilla
Doctor in Medicine and specialist in Pathological Anatomy. Associate Medical Chief of the Anatomic Pathology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid.
Dr. Félix Bonilla Velasco
Physician and Doctor by the Faculty of Medicine of the Universidad Autónoma de Madrid: specialist in Internal Medicine and Medical Oncology.
Dr. Manuel Durán Poveda
D. in Medicine and Surgery from the Universidad Complutense de Madrid. Chief of General and Digestive System Surgery Department, Hospital Universitario Rey Juan Carlos de Madrid. Professor at the Universidad Rey Juan Carlos.
Dr. Jesús San Román
Director of the Department of Medicine and Surgery, Psychology, Preventive Medicine and Public Health and Immunology, Medical Microbiology and Nursing and Stomatology, Faculty of Medicine, Universidad Rey Juan Carlos de Madrid.
Faculty
The Master’s Degree has an international faculty of excellence, composed of professionals and researchers from institutions such as Harvard-Beth Israel Deaconess Medical Center, MD Anderson Cancer Center, Consejo Superior de Investigaciones Científicas (CSIC), Vall d’Hebron Institut de Recerca, among others.
Requirements and Admission
To whom it is addressed
Specialists in Anatomical Oncology
Specialists in Pathology
Hematology Specialists
Radiotherapy Specialists
Other bachelor's or doctoral graduates in the biosanitary field
with interest in tumor disease
Selection and deadlines
To take the Master's degree, the applicant must have a bachelor's degree in the biosanitary area. It is necessary to send your updated CV in order to be evaluated by the Academic Direction.
Admission
Send CV to:
Eva Galián
egalian@ceb.edu.es
Price
COST OF THE MASTER’S DEGREE
The cost of the program is 7100 €. For more information, write to egalian@ceb.edu.es
SPECIAL DISCOUNTS
– 10% discount exclusively for students doing the Residency
– 5 % Special discounts for membership in professional associations (ESMO, ASCO, ESO and IAP).
Not cumulative discounts. Only students who do not receive a scholarship can benefit from these discounts.
For more information, please contact egalian@ceb.edu.es
The Center for Biosanitary Studies has the endorsement of
The Center for Biosanitary Studies is sponsored by the following companies
